RX Inserts “Unreadable?”

Prescription drug insert sheets blasted as “unreadable” … they’re intentionally designed to obscure risks and side effects

Image: Prescription drug insert sheets blasted as “unreadable” … they’re intentionally designed to obscure risks and side effects






(Natural News) If you’ve ever taken a prescription drug, you are probably familiar with those paper inserts that come inside the package – although there’s a good chance you’ve never actually read every word on them. These papers are filled with tiny print outlining the medication’s purpose, dosage, and side effects, but they are so long and technical that few people actually read them from start to finish.

The U.K.’s Academy of Medical Sciences recently slammed the pamphlets in a report, saying that patients find them “unreadable” and “impenetrable” and that they need to be made clearer to increase patient understanding.

The Chair of the report, Professor Sir John Tooke, took pharmaceutical companies to task for the confusing scientific language used in the leaflets. For example, the inserts inside acetaminophen mention the chances of developing pancreatitis and hepatitis but don’t shed light into what those conditions are or just how high the risk is. He says the inserts “aren’t written from a consumer’s perspective.”

Of course, this complex language is really good at accomplishing one thing: making people give up in frustration and ensuring they do not grasp the full extent of the possible side effects that could occur from taking a particular medication. By obscuring the truth about a drug’s side effects and risks, more people will take them and refill their prescription without worrying too much about the repercussions, fattening the wallets of Big Pharma.

By the way, this problem extends to vaccines. In fact, many patients never even read the inserts that come with vaccines because their doctors open up the package and administer it on the spot. If they did read it, they would have known, for example, that the fine print on the package insert of the 2013-2014 flu shot contained mercury, thimerosal and formaldehyde, and that its safety had not been established in pregnant women even though it was administered to them. Even more outrageously, the vaccine comes with just one insert despite being a 10-dose vial intended for 10 different people.

Patients, doctors don’t trust pharmaceutical companies

The Academy of Medical Sciences report also showed that patients trust their friends and family’s opinion more than clinical trial results when it comes to the effectiveness and safety of the drugs they take. After surveying more than 2,000 members of the public and 1,000 doctors, they found that 65 percent of people trust the opinion of their friends and family, while just 37 percent trust medical research evidence.

In addition, they found that 63 percent of the public was skeptical of the claims made by drug trials. Even more concerning was the fact that 82 percent of doctors said they were skeptical of drug trial claims, with the same amount believing that medical research is biased toward making the drugs appear safe and effective. This begs the question of why they continue to prescribe medication if they have such a high degree of mistrust.

The Academy has also proposed a list of questions that patients should ask their doctors when being prescribed medication. It includes questions like how a medication can improve their health and if it can be taken with other medications, but it conveniently omits questions like whether natural or safer alternatives exist.

The FDA reports that medication errors lead to at least one death each day and injure around 1.3 million Americans each year, while the Pharma Death Clock says that nearly 400,000 people have been killed by prescription drugs since 2000. Clear and honest prescription inserts in easy-to-read language and type could go a long way toward helping to prevent many of these unnecessary deaths and injuries.

Sources include:








IPS: Children Treat As Lab Rats!

 IPS – Children Treated as Lab Rats
August 18, 2012

THIRUVANANTHAPURAM, India , Aug 14 2012 (IPS) – Four-year-old Deepak Yadav, a mentally disabled boy from Indore city in the Indian state Madhya Pradesh, was being treated for stomach problems at Chacha Nehru Bal Chikitsalaya, a government hospital for children attached to the M. G. M. Medical College.

(Right to left) Clinical trial victims with medical right activist Dr. Anand Rai. Credit: CTVA, Indore.

But when repeated administration of the anti-ulcer drug Rabeprazole started to exacerbate his condition, his parents stopped treatment and sought help from the Clinical Trial Victims Association (CTVA), which discovered that the boy had been a lab rat for an untested drug.

“We should have been told an unknown drug was being tested on our innocent child and given the choice to say no,” Deepak’s father Sooraj told IPS.

Deepak is now almost entirely reliant on his mother for survival. The family is poor, yet “doctors did not take any steps to get us compensation,” his father added.

This family’s tragic story is just one example of a sinister pattern unfolding across India.

A spate of deaths over the last four years caused by illegal clinical trials of untested drugs has ignited the wrath of rights activists and prompted prominent legal institutions to consider tightening the country’s drug regulation laws. (Read more)

Safe Patient Project

Safe Patient Project

June 15, 2012
Posted by Suzanne Henry in Medical Device Safety |
avery-spp-med-device2Real People, Real Medical Device Stories

FDA Needs More Post-Market Oversight Tools for

Problem Medical Devices Like Faulty Defibrillators

Almost one year after being implanted, the defibrillator lead broke in half inside of my daughter Avery and caused her to have 9 defibrillation shocks.  To any adult, this is scary.  My three year old daughter Avery was convinced for months that there were monsters attacking her and was scared to move.”Molly deGroh, mother of Avery, McHenry, IL

At the age of three, Avery deGroh was implanted with a defibrillator with a Medtronic Sprint Fidelis Lead due to a genetic heart arrhythmia.  The lead connects the defibrillator directly to the heart and delivers an electrical shock when life-threatening heart rhythms occur.

On the day Avery was repeatedly shocked, her parents heard screaming from the basement where she was playing.  Her mother picked her up and could feel her body jolting back and forth and was convinced she was having a cardiac arrest.  Instead, the defibrillator lead was malfunctioning and sending unnecessary shocks to Avery’s heart.  Five days later, Avery had to undergo surgery to replace the faulty device, which can be risky in young children.  Avery was severely traumatized for months after the incident and was always on guard for another attack.

Since 2009, the FDA has received reports of close to 29,000 deaths or injuries from implantable defibrillators, by far the most for any device type.  There have been two major recalls, in 2007 and 2011, of defective leads, the Medtronic Sprint Fidelis and the St. Jude Riata, after they had already been implanted in almost 350,000 patients. Patients with the device leads require close monitoring and face the prospect of needing to have them surgically removed.

Consumers Union urges Congress to adopt provisions from the Senate-passed version of the FDA User Fee Act that will help the FDA better protect patients when safety problems like the ones experienced by Avery and thousands of other patients harmed by faulty medical devices come to light.  These provisions include implementing Unique Device Identifiers  (UDIs) for high risk devices within two years; setting a deadline for when 522 post-market studies must begin;  allowing FDA to order the completion of post-market studies as a condition of approving high-risk devices; and including devices in the Sentinel Initiative without removing important information about serious adverse events.

The House version of the bill does not contain these critical patient safety reforms.

For information contact Lisa McGiffert at lmcgiffert@consumer.org

Article Link:  http://safepatientproject.org/posts/3277-3277

Seven Diseases Big Pharma Hopes You Get in 2012

Seven Diseases Big Pharma Hopes You Get in 2012 | | AlterNet.

Seven Diseases Big Pharma Hopes You Get in 2012

By Martha Rosenberg, AlterNet
Posted on December 6, 2011,

It used to be joked that a consultant is someone who borrows your watch to tell you what time it is. These days, the opportunist is Big Pharma, which raises your insurance premiums and taxes while providing you “low-priced” drugs that you paid for.

How did Pharma get a good third of the United States taking antidepressants, statins, and Purple Pills, albeit at low prices? By selling the diseases of depression, high cholesterol, and gastroesophageal reflux disease, or GERD. Supply-driven marketing, also known as “Have Drug — Need Disease and Patients,” not only turns the nation into pill-popping hypochondriacs, it distracts from Pharma’s drought of real drugs for real medical problems.

Of course, not all diseases are Wall Street pleasers. To be a true blockbuster disease, a condition must (1) really exist but have huge diagnostic “wiggle room” and no clear-cut test, (2) be potentially serious with “silent symptoms” said to “only get worse” if untreated, (3) be “under-recognized,” “under-reported” with “barriers” to treatment, (4) explain hitherto vague health problems a patient has had, (5) have a catchy name — ED, ADHD, RLS, Low T or IBS — and instant medical identity, and (6) need an expensive new drug that has no generic equivalent.

Here are some potential blockbuster diseases Pharma hopes you get in 2012.

Adult ADHD

Everyday problems labeled as “depression” sailed Pharma through the last two decades. You weren’t sad, mad, scared, confused, remorseful, grieving, or even exploited. You were depressed, and there was a pill for that. But depression peaked just like the Atkins Diet and the Macarena. Luckily, there is adult ADHD (Attention Deficit Hyperactivity Disorder), which has doubled in women 45 to 65 and tripled in men and women 20 to 44, according to the Wall Street Journal.

Like depression, adult ADHD is a catch-all category. “Is It ADHD or Menopause?” asks an article in Additude, a magazine devoted exclusively to ADHD. “ADD and Alzheimer’s: Are These Diseases Related?” asks another article in the same magazine.

“I’m Depressed. Could it be ADHD?” says an ad in Psychiatric News, showing a pretty but pouting young woman. In the same publication, another ad titled “Broken Promises” says, “Adults with ADHD were nearly 2x more likely to have been divorced,” while exhorting doctors to “screen for ADHD.”

Adults with ADHD are often “less responsible, reliable, resourceful, goal-oriented, and self-confident, and they find it difficult to define, set, and pursue meaningful internal goals,” says an article cowritten by Harvard child psychiatrist Dr. Joseph Biederman, who is credited with putting “pediatric bipolar disorder” on the map. They “show tendencies to being self-absorbed, intolerant, critical, unhelpful, and opportunistic,” and “tend to be inconsiderate of other people’s rights or feelings,” says the article, describing most people’s brothers-in-law.

Adults with ADHD will have trouble keeping a job and get worse without treatment, says WebMD, tapping into the second requirement of a blockbuster disease — symptoms worsen without pills. “Adults with ADHD may have difficulty following directions, remembering information, concentrating, organizing tasks, or completing work within time limits,” according to the website, whose original partner was Eli Lilly.

How did Pharma get five million kids and now, maybe, their parents on ADHD meds? Ads on 26- by 20-foot screens in Times Square that ask “Can’t focus? Can’t sit still? Could you or your child have ADHD?” four times an hour couldn’t hurt. (Bet no one had trouble focusing on that!)

Still, convincing adults they aren’t sleep deficient or bored but have ADHD is only half the battle. Pharma also has to convince kids who grew up diagnosed as ADHD not to quit their meds, says Mike Cola of Shire (which makes the ADHD drugs Intuniv, Adderall XR, Vyvanse, and the Daytrana patch). “We know that we lose a significant number of patients in the late teen years, early 20s, as they kind of fall out of the system based on the fact that they no longer go to a pediatrician.”

A Shire ad in Northwestern University’s student paper this year takes the issue head on. “I remember being the kid with ADHD. Truth is, I still have it,” says the headline splashed across a photo of Adam Levine, the lead singer of Maroon 5. “It’s Your ADHD. Own It,” was the tagline. (Was “Stay Sick” the runner-up?)

Of course, pushing speed on college kids (or anyone, for that matter) isn’t too hard. Why else do meth dealers say, “First taste free”? But Pharma is so eager to retain its pediatric ADHD market, it has funded for-credit courses for doctors, such as “Identifying, Diagnosing, and Managing ADHD in College Students” and “ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult.”

To make sure no one thinks ADHD is a made-up disease, WebMD shows color-enhanced Pet scans of the brains of a normal person and an ADHD sufferer (flanked by an ad for Vyvanse). But it is doubtful the scans are really different, says psychiatrist Dr. Phillip Sinaikin, author of Psychiatryland. And even if they are, it proves nothing.

“The crux of the matter is that there is simply no definitive understanding of how neuronal activity is related to subjective consciousness, the age-old unsolved body/mind relationship,” Sinaikin told AlterNet. “We have not advanced beyond phrenology, and this article in WebMD is simply the worst kind of manipulation by the drug industry to sell their overpriced products, in this case a desperate effort by Shire to maintain a market share when Adderall goes generic.”

Rheumatoid Arthritis

Rheumatoid arthritis is a serious and dangerous disease. But so are Pharma’s immune-suppressing biologic drugs like Remicade, Enbrel, and Humira, which are pushed to treat it. While RA attacks the body’s own tissues, leading to inflammation of the joints, surrounding tissues, and organs, immune suppressors can invite cancers, lethal infections, and activate TB.

In 2008, the FDA announced that 45 people on Humira, Enbrel, Remicade, and Cimzia died from fungal diseases, and investigated Humira’s links to lymphoma, leukemia, and melanoma in children. This year, the FDA warned that the drugs can cause “a rare cancer of white blood cells” in young people, and the Journal of the American Medical Association (JAMA) warned of “potentially fatal Legionella and Listeria infections.”

Immune-suppressing drugs are also dangerous to the pocketbook. One injection of Remicade costs up to $2,500; a month’s supply of Enbrel costs $1,500; and a year’s supply of Humira costs up to $20,000.

Once upon a time, RA was diagnosed from the presence of “rheumatoid factor” and inflammation. But, thanks to Pharma’s supply-driven marketing, stiffness and pain are all that are required for the diagnosis today. (Athletes and people born before 1970 — line forms to the left!)

In addition to diagnostic wiggle room and a catchy name, RA has other blockbuster disease requirements. It  will “only get worse” if untreated, says WebMD, and it is often “misdiagnosed” and underreported, says Abbott’s Heather Mason, because “people often don’t know what they have for a while.”

So serious a disease, it costs over $20,000 a year to treat but so subtle you may not know you have it? RA sounds like a blockbuster.


Another underreported disease is fibromyalgia, characterized by widespread. unexplained bodily pain. Fibromyalgia is “almost a textbook definition of an unmet medical need,” says Ian Read of Pfizer, which makes the first drug to be approved for fibromyalgia, the seizure pill Lyrica. Pfizer gave nonprofit groups $2.1 million in 2008 to “educate” doctors about fibromyalgia and financed PSAs (pharma service announcements) depicting sufferers describing their symptoms without mentioning a drug. Lyrica now makes $3 billion a year.

Still, Lyrica has to fight Cymbalta, the first antidepressant to be approved for fibromyalgia. Eli Lilly prepositioned Cymbalta for the physical “pain” of depression in a campaign called “Depression Hurts” before the fibromyalgia approval. Treatment of a fibromyalgia patients with either Lyrica or Cymbalta hovers around $10,000, say medical journals.

Pharma and Wall Street may be happy with fibromyalgia drugs, but patients aren’t. On askapatient.com, the drug-rating website, patients on Cymbalta reported chills, jaw problems, electrical “pings” in their brain, and eye problems. This year, four patients reported the urge to kill themselves, a frequently reported side effect of Cymbalta. Lyrica users on askapatient reported memory loss, confusion, extreme weight gain, hair loss, impaired driving, disorientation, twitching, and worse. Some patients take both drugs.


Middle of the Night Insomnia

Sleep disorders are a goldmine for Pharma because everyone sleeps — or watches TV when they can’t. To churn the insomnia market, Pharma rolls out subcategories of insomnia, such as chronic, acute, transient, initial, delayed-onset, terminal, early-morning, menopausal, and the master category of nonrestful sleep. This fall, Pharma rolled out a new version of Ambien for “middle-of-the-night” insomnia called Intermezzo, even though Ambien is paradoxically notorious for middle-of-the-night awakenings: people “waking up” in an Ambien blackout and walking, talking, driving, making phone calls, and eating food.

Many became aware of Ambien’s “lights-on-nobody-home” effect when former Rhode Island Representative Patrick Kennedy drove to Capitol Hill to “vote” at 2:45 a.m. in 2006 on Ambien and crashed his Mustang. But it was Ambien’s EWI effect — eating while intoxicated — not DWIs that gave the pill its worst rap. Fit and sexy people awoke amid mountains of pizza, Krispy Kreme, and Häagen-Dazs cartons, their contents consumed by their evil twin on Ambien.

Excessive Sleepiness and Shift Work Sleep Disorder

Needless to say, people with insomnia won’t be bright-eyed and bushy-tailed the following day —  whether they didn’t sleep or whether they have sleeping pill residues in their system. In fact, they are actually suffering from the underrecognized and underreported epidemic of Excessive Daytime Sleepiness. The main medical causes of EDS or ES are sleep apnea and narcolepsy, but last year Pharma rolled out a lifestyle-caused “Shift Work Sleep Disorder.” (No, it doesn’t meant you can’t sleep because your partner “shifts” in his or her sleep.) Ads for Provigil, a Schedule IV stimulant that treats EDS along with Nuvigil show a judge in his black robe, nodding out on the job, with the headline “Struggling to Fight the Fog?” (“Yo! Your Honor! I’m trying to plead!”).

Of course wakefulness agents contribute to insomnia, which contributes to wakefulness problems in a kind of perpetual pharmaceutical jet lag. In fact, the sleeping pill/alertness aid habit is so common, it threatens to create a new meaning for “AA” — Adderall and Ambien!

Insomnia That Is Really Depression

Sleep disorders have also given a new lease on life to antidepressants. Doctors now prescribe more antidepressants for insomnia than they do sleeping pills, according to CNN. They also often combine them, since “insomnia and depression often occur together, but which is the cause and which is the symptom is often unclear.”

WebMD agrees with doubling the drugs. “Depressed patients with insomnia who were treated with both an antidepressant and a sleep medication fared better than those treated only with antidepressants,” it writes. Ka-ching!

In fact, many of the new blockbuster diseases from adult ADHD and RA to fibromyalgia are treated with new drugs piled on top of existing ones that aren’t working, a Pharma contrivance called polypharmacy. It brings to mind the store owner who says, “I know that 50 percent of my advertising is wasted — I just don’t know which 50 percent.”

Martha Rosenberg frequently writes about the impact of the pharmaceutical, food, and gun industries on public health. Her work has appeared in the Boston Globe, San Francisco Chronicle, Chicago Tribune, and other outlets.

© 2011 Independent Media Institute. All rights reserved.
View this story online at: http://www.alternet.org/story/153332/

Corporations Are Patenting Human Genes and Tissues

Corporations Are Patenting Human Genes and Tissues — Here’s Why That’s Terrifying
By Brad Jacobson, AlterNet
Posted on November 23, 2011, Printed on December 2, 2011

Do you think that granting corporations the rights of people in the Citizens United case is disturbing? Then contemplate the fact that corporations have been patenting human genes and tissues at alarming rates — in the last 30 years, more than 40,000 patents have been granted on genes alone.

As the Occupy movement fights against the unmitigated influence of corporations on our lives, author and medical ethicist Harriet Washington’s new book, Deadly Monopolies: The Shocking Corporate Takeover of Life Itself–And the Consequences for Your Health and Our Medical Future, is a timely wakeup call to protect the very essence of human life from the medical-industrial complex.

In a recent phone interview with AlterNet, Washington discussed the dark implications of corporate medical patents, how we find ourselves in this nightmarish scenario and what needs to be done to stop medical research profits from trumping human health. Washington is also the author of Medical Apartheid, which received the National Book Critics Circle Award. She has been a fellow in medical ethics at Harvard Medical School, a senior research scholar at the National Center for Bioethics at Tuskegee University and a fellow at the Harvard School of Public Health.

Brad Jacobson: The main piece of legislation that opened the door for corporations to begin patenting human life was the Bayh-Dole Act of 1980. Can you tell us how this law was sold to the American people?

Harriet Washington: Just to recap what the Bayh-Dole Act is, basically it was a law that permitted for the first time universities to legally transfer their patents to private corporations, to sell them, license them. That had been virtually prohibited in the past because most of these new inventions had been developed with tax dollars. And the thinking had been, “If you develop things with our tax dollars, then we shouldn’t allow them to go to private corporations who can establish a monopoly with their patents.”

It was sold to the American public primarily by [former Indiana Sen.] Birch Bayh, who of course partnered with [former Kansas Sen.] Bob Dole. But it was Birch Bayh who made the argument that we have all these patents lying around, no one’s doing anything with them. If we let corporations get them, then they’ll develop them into needed medications. So people were told this is the root to get the medications and treatments that we need.

However, what’s really interesting, though — I went behind the scenes and of course I saw that, rather than being any kind of groundswell of popular support, the law actually passed on the last hour of the last day of the last congressional session because of some good ol’ boy networking.

BJ: Also in 1980, the legal counterpart for this corporate opening came with the court decision Diamond v. Chakrabarty, in which a scientist’s patenting of an oil-eating bacteria was contested. But how is this different than what had been patentable in the past?

HW: It’s certainly a good question because living things have been patented in the past. That’s a misconception people have. Louis Pasteur had patented a yeast. Takamine [Hideo] had patented adrenaline. Numerous living things had been patented before. However, there were often legal challenges by people who would say, “This patent is not really valid because you can’t patent a product of nature.”

So in 1980, when Ananda Chakrabarty, a researcher at General Electric, decided to try to patent some bacteria that he had intensively engineered to be able to “eat crude oil,” the U.S.] patent office said, “We’ll patent the process you use, but we’re not going to patent these bacteria. They’re living things and only inventions can be patented. We can’t patent products of nature.”

So Chakrabarty and General Electric sued and the patent office decided to defer to the Supreme Court. The Supreme Court decided that, yes, living things can be patented, which is interesting because Chakrabarty insisted he was shocked by the ruling. He said that he fully expected he had made his case, but he was surprised they decided to more broadly permit the patenting of living things.

But now it’s being applied to things where the contribution of the researcher is nowhere near so extensive. So, of course, genetic sequences found in our body are being patented. Medically important animals — like Harvard’s OncoMouse which is guaranteed to get cancer — are being patented. And so these products of nature, including products of our bodies, being patented has created huge problems for us.  (Read more)

Donations Pour in to Help Woman With Bone Cancer | Community Spirit | Salem News

Donations pour in to help woman with bone cancer | Community Spirit | Salem News.

Donations pour in to help woman with bone cancer | Community Spirit


Donations pour in to help woman with bone cancer

SALEM, Ore. – Donations are pouring in from across the country after the story of a local woman fighting bone cancer went viral on the Internet.

Jan Cline was holding yard sales each weekend in her backyard to raise money to pay her medical bills, but the city of Salem shut her down after a neighbor complained. A city ordinance prohibits people from holding more than three yard sales a year. The city has the ordinance because it says in the past people had set up flea-market-type sales on their property.

The story galvanized people who were outraged the city wouldn’t make an exception for Cline.

As of 10 p.m. Thursday, people have donated $16,500 to help Cline, and earlier in the day Salem’s mayor, Anna Peterson, pledged to help her.

KATU’s original story got picked up by the ABC News website and then by others. Additionally, Cline’s friends set up a website and “it just went into overdrive from 7 o’clock on it just hit the gas,” said computer expert and friend Brad Brunhaver.

Donations and messages have been coming in from places like Lubbock, Texas, Jackson, Miss. and San Jose, Calif.

The mayor of Salem said she’s received phone calls and e-mails from around the country. Peterson’s working to get Cline’s yard sale moved to a commercially zoned location so she can hold more and bigger sales.

“Hopefully, also that other people could donate things to her that she can sell at the garage sale,” she said.

Cline said she’s not thrilled at the idea of moving her yard sales. On principle she thinks the city should make an exception to its rules.

But she’s grateful for people like the man who saw $2 candle sticks in KATU’s story and is sending $100 to buy them.

“I am totally amazed at the generosity of people and how quickly it’s growing,” she said.

To help Jan Cline:

Read KATU’s original story:

Facing Life in Prison for a Miscarriage!

15-Year-Old Girl Faces Life in Prison for a Miscarriage?
By Ed Pilkington, The Guardian
Posted on July 4, 2011, Printed on July 6, 2011


Rennie Gibbs is accused of murder, but the crime she is alleged to have committed does not sound like an ordinary killing. Yet she faces life in prison in Mississippi over the death of her unborn child.

Gibbs became pregnant aged 15, but lost the baby in December 2006 in a stillbirth when she was 36 weeks into the pregnancy. When prosecutors discovered that she had a cocaine habit – though there is no evidence that drug abuse had anything to do with the baby’s death – they charged her with the “depraved-heart murder” of her child, which carries a mandatory life sentence.

Gibbs is the first woman in Mississippi to be charged with murder relating to the loss of her unborn baby. But her case is by no means isolated. Across the US more and more prosecutions are being brought that seek to turn pregnant women into criminals.

“Women are being stripped of their constitutional personhood and subjected to truly cruel laws,” said Lynn Paltrow of the campaign National Advocates for Pregnant Women (NAPW). “It’s turning pregnant women into a different class of person and removing them of their rights.”

Bei Bei Shuai, 34, has spent the past three months in a prison cell in Indianapolis charged with murdering her baby. On 23 December she tried to commit suicide by taking rat poison after her boyfriend abandoned her.

Shuai was rushed to hospital and survived, but she was 33 weeks pregnant and her baby, to whom she gave birth a week after the suicide attempt and whom she called Angel, died after four days. In March Shuai was charged with murder and attempted foeticide and she has been in custody since without the offer of bail. (Read Full Article)

Doctors use Fukushima-like radiation to “treat” thyroid disorders

Doctors use Fukushima-like radiation to “treat” thyroid disorders.

Doctors use Fukushima-like radiation to “treat” thyroid disorders
by Mike Adams, the Health Ranger, NaturalNews Editor


Radiation Danger



(NaturalNews) Japan has been reporting for several days that much of the raw milk being produced in the Fukushima province is now radioactive. This raises today’s quiz question: If the FDA were operating in Japan, what would they do about this raw, radioactive milk?

Answer: They would seize it because it’s RAW, not because it’s radioactive.

After all, it is the FDA that has long supported the mass irradiation of the food supply as a way to sterilize it and “kill pathogens.” The food irradiation agenda has long been a top priority of the FDA (http://www.naturalnews.com/023015_f…). Meanwhile, the FDA has been a steady enemy of raw milk (and other raw foods).

Even today, when you buy almonds grown in California, they must be fumigated or irradiated in order to comply with California state law (which was supported by the USDA and applauded by the FDA). (http://www.naturalnews.com/021989.html)

Perhaps the Fukushima nuclear power plant has a future after all: Instead of producing power, it can function as an FDA-approved food irradiation center where fresh, raw foods are exposed to radiation to make them “safe” for public consumption.

Does your doctor want to irradiate your thyroid gland?

It’s not just your food that’s being irradiated, of course: It’s also your body. In addition to the radiation-emitting mammography machines and cancer radiotherapy treatment machines used in hospitals every day, there’s also a very common radiation treatment for so-called “hyperthyroidism” that involves injecting a radioactive form of iodine into patients and “burning out” their thyroid gland.

Guess what they use for their thyroid radiation treatment? Radioactive iodine — the same deadly substance being released from the Fukushima power plant!

I can’t make this stuff up. The treatment is so dangerous that patients who subject themselves to it set off radiation alarms at airports and transportation centers. The patients are so radioactive that they’re told not to stand near any other person for several days because the radiation would damage them. From EPA.gov:

“Key beta emitters used in medical imaging, diagnostic and treatment procedures are phosphorus-32, and iodine-131. For example, people who have taken radioactive iodine will emit beta particles. They must follow strict procedures to protect family members from exposure.

Radioactive iodine may enter the environment during a nuclear reactor accident and find its way into the food chain.

Industrial gauges and instruments containing concentrated beta-emitting radiation sources can be lost, stolen, or abandoned. If these instruments then enter the scrap metal market, or someone finds one, the sources they contain can expose people to beta emitters.” (http://www.epa.gov/radiation/unders…)  (READ FULL ARTICLE)

When It Comes to Natural Health for Children, We’re Living in a Police State | Welcome to the Alliance for Natural Health – USA

When It Comes to Natural Health for Children, We’re Living in a Police State | Welcome to the Alliance for Natural Health – USA.


hen It Comes to Natural Health for Children, We’re Living in a Police State

Posted By ANH-USA On April 5, 2011 @ 11:00 am In Uncategorized | No Comments

iStock_000011966456XSmallIncreasingly, state governments are determining what treatments a child can and cannot have—regardless of parents’ wishes. Three shocking stories prove the point.

In April 2003, Barbara Jensen took her son Parker, then twelve years old, to an oral surgeon to have a small growth removed from his tongue. The growth was diagnosed as Ewing’s sarcoma, a rare and aggressive form of cancer. The medical center at the University of Utah recommended surgery and chemotherapy. The chemotherapy was very aggressive and ran the risk of making Parker sterile and stunting his growth. The parents refused treatment even though doctors said chemotherapy was imperative, and instead sought second and third opinions (they believed he had been misdiagnosed) and considered alternative therapies.

The doctor who provided the diagnosis went to the state Division of Child and Family Services (DCFS) and filed a medical neglect complaint against the Jensens in juvenile court, obtained a court order requiring chemotherapy, and a judge ordered the state of Utah to take custody of the boy.

The Jensens violated the order by moving to Idaho, whereupon they were charged with kidnaping and custodial interference. Parker’s father, Daren Jensen, was arrested, spent four nights in jail, and lost his job. Under political pressure the DCFS dismissed the petition, the criminal charges were downgraded to custodial interference, the parents were given one year of probation, and the record was finally expunged.

However, the deal that the Jensens struck also stipulated that they would take Parker to an oncologist of their choice in Idaho, and follow the doctor’s advice. On September 26, 2003, the Jensens announced that no cancer had been found, though a report later that week contradicted that information, claiming that chemo was being called for.

Parker never did have chemotherapy, the state eventually backed down under media scrutiny, and the 2004 and 2005 sessions of Utah’s state assembly were rife with “Parker Jensen laws” to protect the rights of parents.

In 2005, the Jensens sued [1] University of Utah doctors and DCFS workers, arguing that Article 1 of the Utah Constitution includes “the fundamental right to make decisions regarding one’s family, including health matters.” The case was eventually heard by the Utah Supreme Court. Its March 29 ruling [2] found that Parker Jensen and his parents have no legal claim against the state, its employees, or the doctors who turned him into DCFS.

Happily, Parker is alive and well at 20 years old. It is very possible he never had cancer. The conventional medical paradigm is quick to diagnose and prescribe aggressive, toxic treatments such as chemotherapy and surgery—despite the fact that it is not always effective and often dangerous [3]. We shouldn’t penalize patients simply for looking for alternative treatments. (READ MORE)

Blood pressure chart: What your reading means – MayoClinic.com

Mayo Clinic Housecall


Blood pressure chart: What your reading means

By Mayo Clinic staff

Blood Pressure Monitor

This blood pressure chart can help you figure out if your blood pressure is at a healthy level or if you’ll need to take some steps to improve your numbers.

Blood pressure readings fall into four general categories, ranging from normal to stage 2 hypertension (high blood pressure). The level of your blood pressure determines what kind of treatment you may need. To get an accurate blood pressure measurement, your doctor should evaluate your readings based on the average of two or more blood pressure readings on each of two office visits.

Here’s a look at the four blood pressure categories and what they mean for you. If your readings fall into two different categories, your correct blood pressure category is the higher category. For example, if your blood pressure reading is 125/95 millimeters of mercury (mm Hg), you have stage 1 hypertension.    (Learn  more)

« Older entries